Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Theravance Inc (NASDAQ:THRX)

13.91
Delayed Data
As of Aug 31
 +0.09 / +0.65%
Today’s Change
10.58
Today|||52-Week Range
23.84
-1.70%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Revenue and IncomeNet Revenues4.2M10.7M10.4M14.1M
 
 
 
 
 
Depreciation And Amortization6.9M3.5M3.5M3.5M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses6.9M7.2M6.1M5.5M
 
 
 
 
 
Research And Development1.9M777.0K712.0K638.0K
 
 
 
 
 
Total Operating Expenses13.8M10.6M9.6M9.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-9.5M130.0K745.0K5.1M
 
 
 
 
 
Interest Expense On Debt12.4M12.6M12.7M13.0M
 
 
 
 
 
Other Expenses255.0K-3.6M1.2M-16.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-21.5M-15.9M-10.7M-7.8M
 
 
 
 
 
Income Taxes-278.0K0.000.000.00
 
 
Net Income-21.3M-15.9M-10.7M-7.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS113.1M114.3M114.7M115.3M
 
 
 
 
 
Shares To Calculate EPS Diluted113.1M114.3M114.7M115.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.19-$0.14-$0.09-$0.07
 
 
 
 
 
EPS Diluted-$0.19-$0.14-$0.09-$0.07